Related Experiment Videos
Ganglion blocking effects of streptomycin
Archives Internationales De Pharmacodynamie Et De Therapie
|March 1, 1978
Summary
Streptomycin blocks nerve signals in the superior cervical ganglion, primarily by reducing acetylcholine release from presynaptic nerve terminals. This effect is dose-dependent and can be counteracted by calcium.
Area of Science:
- Neuroscience
- Pharmacology
- Cellular Biology
Background:
- The superior cervical ganglion (SCG) is crucial for sympathetic nervous system function.
- Understanding drug effects on neuronal transmission is vital for therapeutic development.
Purpose of the Study:
- To investigate the precise mechanisms by which streptomycin affects neuronal signaling within the SCG.
- To elucidate the impact of streptomycin on different components of nerve action potentials.
Main Methods:
- Electrophysiological recordings were performed on rabbit and rat SCG.
- The effects of varying streptomycin concentrations on preganglionic and postganglionic action potentials were analyzed.
- The influence of extracellular calcium levels was examined.
Main Results:
- Streptomycin exhibited a dose-dependent blockade of the postganglionic compound action potential.
- A preferential block of the initial spike (S1) was observed, with higher concentrations affecting the second spike (S2).
- Presynaptic nerve terminal action potential amplitude was reduced, while preganglionic nerve action potentials remained largely unaffected. Calcium ions antagonized streptomycin's blocking effect.
Conclusions:
- Ganglionic blockade by streptomycin is primarily mediated by a presynaptic mechanism.
- This presynaptic action likely involves a reduction in acetylcholine release.
- The findings provide insight into streptomycin's neurotoxic potential and its interaction with calcium signaling.